Each year, the Brotman Baty Institute (BBI) awards grants to encourage engaging and impactful research among investigators across the three founding institutions (UW, FHCRC, Seattle Children’s) with clear relevance to precision medicine. Since the program was launched in 2018, these “catalytic collaborations” have led to inspired discoveries, numerous papers published in peer-reviewed journals, and have been leveraged to acquire additional funds from private and public sector donors, including R01 grants from the National Institutes of Health. There are two award categories – Catalytic Collaborations and Precision Medicine Clinical Labs – and each has two funding levels for faculty and trainees. All grant proposals are reviewed by a committee composed of faculty from all three institutions; the committee’s recommendations are then provided to the BBI Scientific Director Dr. Jay Shendure. These grants underscore BBI’s commitment to facilitating innovation among its members and trainees.
